Hortobagyi GN - Search Results

1

Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.

Yang JY, Chang CJ, Xia W, Wang Y, Wong KK, Engelman JA, Du Y, Andreeff M, Hortobagyi GN, Hung MC. Yang JY, et al. Among authors: hortobagyi gn. Cancer Res. 2010 Jun 1;70(11):4709-18. doi: 10.1158/0008-5472.CAN-09-4524. Epub 2010 May 18. Cancer Res. 2010. PMID: 20484037 Free PMC article.

2

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.

Walters RS, Frye D, Buzdar AU, Holmes FA, Hortobagyi GN. Walters RS, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):476-81. doi: 10.1002/1097-0142(19920115)69:2<476::aid-cncr2820690234>3.0.co;2-0. Cancer. 1992. PMID: 1728377 Clinical Trial.

3

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

4

Sequential cyclic combined hormonal therapy for metastatic breast cancer.

Hortobagyi GN, Hug V, Buzdar AU, Kau SW, Holmes FA, Fritsche HA. Hortobagyi GN, et al. Cancer. 1989 Sep 1;64(5):1002-6. doi: 10.1002/1097-0142(19890901)64:5<1002::aid-cncr2820640505>3.0.co;2-b. Cancer. 1989. PMID: 2527085

5

Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.

Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M. Ro J, et al. Among authors: hortobagyi gn. Cancer Res. 1988 Jan 1;48(1):161-4. Cancer Res. 1988. PMID: 3334990

6

Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy.

Cho SH, Sahin A, Hortobagyi GN, Hittelman WN, Dhingra K. Cho SH, et al. Among authors: hortobagyi gn. Cancer Res. 1994 Dec 15;54(24):6302-5. Cancer Res. 1994. PMID: 7987817

7

Multidisciplinary management of advanced primary and metastatic breast cancer.

Hortobagyi GN. Hortobagyi GN. Cancer. 1994 Jul 1;74(1 Suppl):416-23. doi: 10.1002/cncr.2820741329. Cancer. 1994. PMID: 8004615 Review.

8

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.

Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC. Chang JY, et al. Among authors: hortobagyi gn. Oncogene. 1997 Feb 6;14(5):561-8. doi: 10.1038/sj.onc.1200861. Oncogene. 1997. PMID: 9053854

9

The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy.

Kinney AY, Sahin A, Vernon SW, Frankowski RF, Annegers JF, Hortobagyi GN, Buzdar AU, Frye DK, Dhingra K. Kinney AY, et al. Among authors: hortobagyi gn. Cancer. 1997 Dec 15;80(12):2240-9. doi: 10.1002/(sici)1097-0142(19971215)80:12<2240::aid-cncr4>3.0.co;2-y. Cancer. 1997. PMID: 9404700 Clinical Trial.

10

Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.

Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hoff PM, et al. Among authors: hortobagyi gn. Cancer. 1998 Mar 1;82(5):965-9. doi: 10.1002/(sici)1097-0142(19980301)82:5<965::aid-cncr23>3.0.co;2-y. Cancer. 1998. PMID: 9486588 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters